Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy-Reference-Cited by-同舟云学术

Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy

Published:2004-02 Issue:2 Volume:144 Page:235-239
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Rouse Bobbye,Azen Colleen

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference9 articles.

1. Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies;Lenke;N Engl J Med,1980

2. Projections of a rebound in frequency of mental retardation from phenylketonuria;Kirkman;Appl Res Ment Retard,1982

3. The international collaborative study of maternal phenylketonuria (PKU): organization, study design and description of the sample;Friedman;Eur J Pediatr,1996

4. The international survey of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study;Platt;Am J Obstet Gynecol,2000

5. The international collaborative study of maternal PKU status report 1998;Koch;Ment Retard Dev Dis Res Rev,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in 14 live births resulting from Pegvaliase-treated pregnancies in PKU-affected females;Molecular Genetics and Metabolism;2024-03

2. Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman;JIMD Reports;2023-07-25

3. Phenylketonuria and the brain;Molecular Genetics and Metabolism;2023-05

4. Homocysteine and methylmalonic acid in Phenylketonuria patients;Genetics and Molecular Biology;2023

5. Nutrition Management of Maternal Metabolic Disorders;Nutrition Management of Inherited Metabolic Diseases;2022